1Megraud F.H.pylori antibiotic resistance:prevalence,importance,and advances in testing.Gut,2004,53:1374-1384.
2Di Caro S,Ojetti V,Zocco MA,et al.Mono,dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.Aliment Pharmacol Ther,2002,16:527-532.
3Jadad AR,Moore RA,Carroll D,et al.Assessing the quality of reports of randomized clinical trials:is blinding necessary? Control Clin Trials,1996,17:1-12.
4Bago P.Vcev A,Tomic M,et al.High eradication rate of H.pylori with moxifloxacin-based treatment:a randomized controlled trial.Wien Klin Wochenschr,2007,119:372-378.
5Nista EC,Candelli M,Zocco MA,et al.Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.Aliment Pharmacol Ther,2005,21:1241-1247.
6Kilic ZM,Koksal AS.Cakal B,et al.Moxifloxacine plus arnoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection.Dig Dis Sci,2008,53:3133-3137.
7Cattoir V,Nectoux J,Lascols C,et al.Update on fluoroquinolone resistance in Helicobacter pylori:new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.Int J Antimicrob Agents,2007,29:389-396.
8Miehlke S.Schneider-Brachen W.Kitsch C,et al.One-week once-daily triple therapy with esomeprazole,moxifloxacin,and rifabutin for eradicafion of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin.Helicobacter,2008,13:69-74.
